Artificial Intelligence in Diagnostics Market 2030 Size Reached US$ 10.8 Bn by 2030

The global Artificial Intelligence in Diagnostics market size is expected to be worth around US$ 10.8 billion by 2030, according to a new report by Vision Research Reports.

The global Artificial Intelligence in Diagnostics market size was valued at US$ 540.3 Mn in 2020 and is anticipated to grow at a CAGR of 35.8% during forecast period 2021 to 2030.

Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchrepo... 

Artificial Intelligence in Diagnostics Market (By Component: Software, Hardware, Services; By Diagnosis Type: Cardiology, Oncology, Pathology, Radiology, Chest and Lung, Neurology, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Growth Factors

Rising number of AI-based diagnostic startups in healthcare sector along with increasing investments by venture capitalists for development of newer and innovative technologies which can provide effective and fast results with respect to diagnostic processes is supporting the market growth.

Based on component, the software segment dominated the market with a share of 44.3% in 2020. This high share is attributable to the rising demand for AI-powered software tools and cloud-based solutions for diagnostic purposes. In addition, technological advancements in artificial intelligence-based software by integration of multiple data points such as CT, and genomics for precise diagnosis and detection are further propelling the overall growth and adoption.

Report Highlights

The software segment dominated the market and accounted for the largest revenue share of 54.3% in 2020. Increasing demand for cloud-based and AI-powered or augmented diagnostic solutions to increase diagnostic precision while analyzing and interpreting medical images of a patient is boosting segment growth.

The neurology segment dominated the market for artificial intelligence in diagnostics and accounted for the largest revenue share of 34.7% in 2020. Increasing consumer shift toward value-based care, early diagnosis and precise detection provided by artificial intelligence-based solutions, and rising prevalence of various neurological diseases, such as epilepsy, Alzheimer's disease, ischemic brain stroke, Parkinson’s disease and multiple sclerosis, is driving the segment growth.

North America dominated the artificial intelligence in diagnostics market and accounted for the highest revenue share of 65.9%. The region is anticipated to grow at the fastest rate during the forecast period. The presence of an established healthcare sector, growing adoption of healthcare IT solutions in medical diagnosis, and lucrative funding options available for the development of AI-based diagnosis software are factors contributing to regional market growth.

Key Players

• Aidoc
• AliveCor
• GE Healthcare
• Imagen Technologies
• Vuno Inc.
• IDx Technologies Inc.
• Siemens Healthcare GmbH
• Neural Analytics
• Riverain Technologies
• Zebra Medical Vision

Market Segmentation

• Component Outlook
  • Software
  • Hardware
  • Services
• Diagnosis Type Outlook
  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Chest and Lung
  • Neurology
  • Others
• Regional Outlook
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Singapore
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Table of Contents

Chapter 1. Introduction

1. 1.1. Research Objective
2. 1.2. Scope of the Study
3. 1.3. Definition
4. Chapter 2. Research Methodology
5. 2.1. Research Approach
6. 2.2. Data Sources
7. 2.3. Assumptions & Limitations
8. Chapter 3. Executive Summary
9. 3.1. Market Snapshot
10. Chapter 4. Market Variables and Scope
11. 4.1. Introduction
12. 4.2. Market Classification and Scope
13. 4.3. Industry Value Chain Analysis
14. 4.3.1. Raw Material Procurement Analysis
15. 4.3.2. Sales and Distribution Channel Analysis
16. 4.3.3. Downstream Buyer Analysis
17. Chapter 5. Market Dynamics Analysis and Trends
18. 5.1. Market Dynamics
19. 5.1.1. Market Drivers
20. 5.1.2. Market Restraints
21. 5.1.3. Market Opportunities
22. 5.2. Porter’s Five Forces Analysis
23. 5.2.1. Bargaining power of suppliers
24. 5.2.2. Bargaining power of buyers
25. 5.2.3. Threat of substitute
26. 5.2.4. Threat of new entrants
27. 5.2.5. Degree of competition
28. Chapter 6. Competitive Landscape
29. 6.1.1. Company Market Share/Positioning Analysis
30. 6.1.2. Key Strategies Adopted by Players
31. 6.1.3. Vendor Landscape
32. 6.1.3.1. List of Suppliers
33. 6.1.3.2. List of Buyers
34. Chapter 7. Global Artificial Intelligence in Diagnostics Market, By Component
35. 7.1. Artificial Intelligence in Diagnostics Market, by Component, 2021-2030
36. 7.1.1. Software
37. 7.1.1.1. Market Revenue and Forecast (2016-2030)
38. 7.1.2. Hardware
39. 7.1.2.1. Market Revenue and Forecast (2016-2030)
40. 7.1.3. Services
41. 7.1.3.1. Market Revenue and Forecast (2016-2030)
42. Chapter 8. Global Artificial Intelligence in Diagnostics Market, By Diagnosis Type
43. 8.1. Artificial Intelligence in Diagnostics Market, by Diagnosis Type, 2021-2030
44. 8.1.1. Cardiology
45. 8.1.1.1. Market Revenue and Forecast (2016-2030)
46. 8.1.2. Oncology
47. 8.1.2.1. Market Revenue and Forecast (2016-2030)
48. 8.1.3. Pathology
49. 8.1.3.1. Market Revenue and Forecast (2016-2030)
50. 8.1.4. Radiology
51. 8.1.4.1. Market Revenue and Forecast (2016-2030)
52. 8.1.5. Chest and Lung
53. 8.1.5.1. Market Revenue and Forecast (2016-2030)
54. 8.1.6. Neurology
55. 8.1.6.1. Market Revenue and Forecast (2016-2030)
56. 8.1.7. Others
57. 8.1.7.1. Market Revenue and Forecast (2016-2030)
58. Chapter 9. Global Artificial Intelligence in Diagnostics Market, Regional Estimates and Trend Forecast
59. 9.1. North America
60. 9.1.1. Market Revenue and Forecast, by Component (2016-2030)
61. 9.1.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
62. 9.1.3. U.S.
63. 9.1.3.1. Market Revenue and Forecast, by Component (2016-2030)
64. 9.1.3.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
65. 9.1.4. Rest of North America
66. 9.1.4.1. Market Revenue and Forecast, by Component (2016-2030)
67. 9.1.4.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
68. 9.2. Europe
69. 9.2.1. Market Revenue and Forecast, by Component (2016-2030)
70. 9.2.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
71. 9.2.3. UK
72. 9.2.3.1. Market Revenue and Forecast, by Component (2016-2030)
73. 9.2.3.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
74. 9.2.4. Germany
75. 9.2.4.1. Market Revenue and Forecast, by Component (2016-2030)
76. 9.2.4.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
77. 9.2.5. France
78. 9.2.5.1. Market Revenue and Forecast, by Component (2016-2030)
79. 9.2.5.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
80. 9.2.6. Rest of Europe
81. 9.2.6.1. Market Revenue and Forecast, by Component (2016-2030)
82. 9.2.6.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
83. 9.3. APAC
84. 9.3.1. Market Revenue and Forecast, by Component (2016-2030)
85. 9.3.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
86. 9.3.3. India
87. 9.3.3.1. Market Revenue and Forecast, by Component (2016-2030)
88. 9.3.3.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
89. 9.3.4. China
90. 9.3.4.1. Market Revenue and Forecast, by Component (2016-2030)
91. 9.3.4.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
92. 9.3.5. Japan
93. 9.3.5.1. Market Revenue and Forecast, by Component (2016-2030)
94. 9.3.5.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
95. 9.3.6. Rest of APAC
96. 9.3.6.1. Market Revenue and Forecast, by Component (2016-2030)
97. 9.3.6.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
98. 9.4. MEA
99. 9.4.1. Market Revenue and Forecast, by Component (2016-2030)
100. 9.4.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
101. 9.4.3. GCC
102. 9.4.3.1. Market Revenue and Forecast, by Component (2016-2030)
103. 9.4.3.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
104. 9.4.4. North Africa
105. 9.4.4.1. Market Revenue and Forecast, by Component (2016-2030)
106. 9.4.4.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
107. 9.4.5. South Africa
108. 9.4.5.1. Market Revenue and Forecast, by Component (2016-2030)
109. 9.4.5.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
110. 9.4.6. Rest of MEA
111. 9.4.6.1. Market Revenue and Forecast, by Component (2016-2030)
112. 9.4.6.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
113. 9.5. Latin America
114. 9.5.1. Market Revenue and Forecast, by Component (2016-2030)
115. 9.5.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
116. 9.5.3. Brazil
117. 9.5.3.1. Market Revenue and Forecast, by Component (2016-2030)
118. 9.5.3.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
119. 9.5.4. Rest of LATAM
120. 9.5.4.1. Market Revenue and Forecast, by Component (2016-2030)
121. 9.5.4.2. Market Revenue and Forecast, by Diagnosis Type (2016-2030)
122. Chapter 10. Company Profiles
123. 10.1. Aidoc
124. 10.1.1. Company Overview
125. 10.1.2. Product Offerings
126. 10.1.3. Financial Performance
127. 10.1.4. Recent Initiatives
128. 10.2. AliveCor
129. 10.2.1. Company Overview
130. 10.2.2. Product Offerings
131. 10.2.3. Financial Performance
132. 10.2.4. Recent Initiatives
133. 10.3. GE Healthcare
134. 10.3.1. Company Overview
135. 10.3.2. Product Offerings
136. 10.3.3. Financial Performance
137. 10.3.4. Recent Initiatives
138. 10.4. Imagen Technologies
139. 10.4.1. Company Overview
140. 10.4.2. Product Offerings
141. 10.4.3. Financial Performance
142. 10.4.4. Recent Initiatives
143. 10.5. Vuno Inc.
144. 10.5.1. Company Overview
145. 10.5.2. Product Offerings
146. 10.5.3. Financial Performance
147. 10.5.4. Recent Initiatives
148. 10.6. IDx Technologies Inc.
149. 10.6.1. Company Overview
150. 10.6.2. Product Offerings
151. 10.6.3. Financial Performance
152. 10.6.4. Recent Initiatives
153. 10.7. Siemens Healthcare GmbH
154. 10.7.1. Company Overview
155. 10.7.2. Product Offerings
156. 10.7.3. Financial Performance
157. 10.7.4. Recent Initiatives
158. 10.8. Riverain Technologies
159. 10.8.1. Company Overview
160. 10.8.2. Product Offerings
161. 10.8.3. Financial Performance
162. 10.8.4. Recent Initiatives
163. 10.9. Zebra Medical Vision
164. 10.9.1. Company Overview
165. 10.9.2. Product Offerings
166. 10.9.3. Financial Performance
167. 10.9.4. Recent Initiatives
168. Chapter 11. Research Methodology
169. 11.1. Primary Research
170. 11.2. Secondary Research
171. 11.3. Assumptions
172. Chapter 12. Appendix

12.1. About Us

Glossary of Terms

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Buy This Premium Research Report, click here@ https://www.visionresearchrepo... or call: +1 9197 992 333